BCM
PHIO icon

Bridgeway Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Bridgeway Capital Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,610
Closed -$16.4K – 1303
2024
Q2 		$16.4K Hold
2,610
– – ﹤0.01% 1256
2024
Q1 		$16K Hold
2,610
– – ﹤0.01% 1297
2023
Q4 		$17.8K Hold
2,610
– – ﹤0.01% 1343
2023
Q3 		$35.2K Hold
2,610
– – ﹤0.01% 1325
2023
Q2 		$67.4K Buy
+2,610
New +$91.7K ﹤0.01% 1307

Other funds holding PHIO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgeway Capital Management's PHIO Position: Q3 2024 in Review

Bridgeway Capital Management sold out of Phio Pharmaceuticals (PHIO) in Q3 2024, closing a stake of 2,610 shares — an estimated $16.4K sold.

Bridgeway Capital Management first reported a position in PHIO in Q2 2023 and held it in 5 quarters. The position peaked at $67.4K in Q2 2023. 6 funds tracked by Wall St. Rank hold PHIO as of Q3 2024.

  • Bridgeway Capital Management reported no remaining Phio Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,610 Phio Pharmaceuticals shares in Q3 2024, an estimated $16.4K.
  • Bridgeway Capital Management first reported a position in Phio Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Bridgeway Capital Management's Phio Pharmaceuticals position peaked at $67.4K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.